MedPath

University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices

Completed
Conditions
Defibrillator
Pacemaker
MRI
Registration Number
NCT02548819
Lead Sponsor
University Health Care System, Augusta, Georgia
Brief Summary

A single-center registry to prospectively evaluate the safety of non-cardiac/non-thoracic magnetic resonance imaging (MRI) in patients with implanted cardiac devices (pacemakers and implantable cardioverter defibrillators).

Detailed Description

Evaluation of safety of MR scanning of patients with implanted cardiac devices. Device parameters pre and post MR imaging will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Male or female 18 years or older
  • Informed consent can be provided by patient or medical power of attorney
  • Presence of implanted pacemaker or ICD
  • MRI is the diagnostic modality of choice for a specific clinical scenario without acceptable alternative imaging technology as determined by ordering physician
  • Non-cardiac/non-thoracic MRI ordered
Exclusion Criteria
  • Presence of metallic objects that represent a contraindication to MR imaging
  • Morbid obesity which results in body contact with the magnet façade
  • Pacemaker or ICD generator implanted prior to 2002
  • ICD patients who are pacing dependent
  • Pregnancy
  • Device generator at ERI (elective replacement interval)
  • Presence of other active implanted medical device
  • Presence of abandoned leads (with the exception of post CABG temporary epicardial pacing wires)
  • Presence of implanted cardiac device in the abdominal position
  • Pacemaker or ICD that is labeled as MRI-Conditional by the FDA
  • Pacemaker or ICD implanted less than 6 weeks prior to MRI scan

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Battery voltageImmediate

Change in voltage \> 0.04 V

Pacing lead impedanceImmediate

Change in impedance \> 50 Ohms

Shock impedanceImmediate

Change in impedance \> 3 Ohms

P wave amplitudeImmediate

Decrease in amplitude \> 50%

R wave amplitudeImmediate

Decrease in amplitude \> 25%

Pacing lead thresholdImmediate

Threshold increase \> 0.5 V at a fixed pulse width of 0.4ms

Adverse eventImmediate

An adverse clinical event

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital

🇺🇸

Augusta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath